RXi Pharmaceuticals Corp. Company Profile (NASDAQ:RXII)

About RXi Pharmaceuticals Corp.

RXi Pharmaceuticals Corp. logoRXi Pharmaceuticals Corporation is a clinical-stage ribonucleic acid (RNA) interference (RNAi) company developing therapeutics in dermatology and ophthalmology that address unmet medical needs. The Company's development programs are based on its self-delivering RNAi (sd-rxRNA) platform and Samcyprone, a topical immunomodulator. Its clinical development programs include RXI-109, an sd-rxRNA, for the treatment of dermal and ocular scarring, and Samcyprone for the treatment of such disorders as warts, alopecia areata, non-malignant skin tumors and cutaneous metastases of melanoma. Its pipeline is focused on approximately three areas, including dermatology, ophthalmology and cosmetic product development. Its RNAi therapies are designed to silence, or down-regulate, the expression of a specific gene that may be over-expressed in a disease condition and its immunotherapy agent treats diseases by inducing, enhancing or suppressing an immune response.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: RXII
  • CUSIP:
Key Metrics:
  • Previous Close: $1.94
  • 50 Day Moving Average: $2.25
  • 200 Day Moving Average: $2.35
  • 52-Week Range: $1.26 - $6.49
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.50
  • P/E Growth: 0.00
  • Market Cap: $12.72M
  • Outstanding Shares: 6,559,000
  • Beta: 0.91
Profitability:
  • Return on Equity: -120.07%
  • Return on Assets: -99.19%
Debt:
  • Current Ratio: 4.10%
  • Quick Ratio: 4.10%
Additional Links:
Companies Related to RXi Pharmaceuticals Corp.:

Analyst Ratings

Consensus Ratings for RXi Pharmaceuticals Corp. (NASDAQ:RXII) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $3.50 (80.41% upside)

Analysts' Ratings History for RXi Pharmaceuticals Corp. (NASDAQ:RXII)
Show:
DateFirmActionRatingPrice TargetDetails
6/7/2016HC WainwrightInitiated CoverageBuy$3.50View Rating Details
(Data available from 9/27/2014 forward)

Earnings

Earnings History for RXi Pharmaceuticals Corp. (NASDAQ:RXII)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2016        
8/11/2016Q216($0.36)($0.34)ViewListenView Earnings Details
5/13/2016Q116($0.45)($0.34)$34.00 million$10.00 millionViewListenView Earnings Details
3/30/2016Q415($0.05)($0.04)ViewListenView Earnings Details
11/12/2015Q315($0.04)($0.04)ViewListenView Earnings Details
8/12/2015Q215($0.09)($0.05)ViewListenView Earnings Details
5/13/2015Q115($0.10)($0.13)ViewListenView Earnings Details
3/30/2015Q414($0.14)($0.13)ViewN/AView Earnings Details
11/13/2014Q314($0.22)($0.17)ViewN/AView Earnings Details
8/14/2014Q214($0.25)($0.23)ViewN/AView Earnings Details
5/14/2014Q114($0.31)($0.32)ViewN/AView Earnings Details
3/28/2014($0.31)$0.84ViewN/AView Earnings Details
11/14/2012Q312($0.02)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for RXi Pharmaceuticals Corp. (NASDAQ:RXII)
Current Year EPS Consensus Estimate: $-1.40 EPS
Next Year EPS Consensus Estimate: $-1.29 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.05)($0.05)($0.05)
Q3 20161($0.32)($0.32)($0.32)
Q4 20161($0.23)($0.23)($0.23)
Q1 20171($0.20)($0.20)($0.20)
Q2 20171($0.20)($0.20)($0.20)
Q3 20171($0.17)($0.17)($0.17)
Q4 20171($0.17)($0.17)($0.17)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for RXi Pharmaceuticals Corp. (NASDAQ:RXII)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for RXi Pharmaceuticals Corp. (NASDAQ:RXII)
Insider Ownership Percentage: 3.96%
Institutional Ownership Percentage: 11.76%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/2/2015Geert CauwenberghCEOBuy5,000$0.72$3,600.00View SEC Filing  
2/17/2015Geert CauwenberghCEOBuy4,000$1.17$4,680.00View SEC Filing  
2/10/2015Geert CauwenberghCEOBuy2,000$1.24$2,480.00View SEC Filing  
1/22/2015Robert J BittermanDirectorBuy5,000$1.20$6,000.00View SEC Filing  
1/20/2015Geert CauwenberghCEOBuy10,000$1.03$10,300.00View SEC Filing  
12/30/2014Geert CauwenberghCEOBuy2,500$1.59$3,975.00View SEC Filing  
10/13/2014Geert CauwenberghCEOBuy3,000$1.68$5,040.00View SEC Filing  
9/19/2014Geert CauwenberghCEOBuy4,500$2.20$9,900.00View SEC Filing  
9/16/2014Geert CauwenberghCEOBuy5,000$2.08$10,400.00View SEC Filing  
9/15/2014Geert CauwenberghCEOBuy10,000$2.18$21,800.00View SEC Filing  
7/15/2014Geert CauwenberghCEOBuy1,000$2.50$2,500.00View SEC Filing  
7/9/2014Geert CauwenberghCEOBuy1,400$2.57$3,598.00View SEC Filing  
7/2/2014Geert CauwenberghCEOBuy2,000$2.86$5,720.00View SEC Filing  
6/19/2014Geert CauwenberghCEOBuy2,000$2.98$5,960.00View SEC Filing  
6/9/2014Geert CauwenberghCEOBuy1,000$3.05$3,050.00View SEC Filing  
6/4/2014Geert CauwenberghCEOBuy2,000$2.94$5,880.00View SEC Filing  
10/31/2013Geert CauwenberghCEOBuy1,000$3.17$3,170.00View SEC Filing  
10/23/2013Geert CauwenberghCEOBuy1,000$3.34$3,340.00View SEC Filing  
10/9/2013Geert CauwenberghCEOBuy1,000$3.15$3,150.00View SEC Filing  
8/29/2013Curtis LockshinDirectorBuy1,000$3.70$3,700.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for RXi Pharmaceuticals Corp. (NASDAQ:RXII)
DateHeadline
News IconPenny Stock Investors are Growing Curious About RXi Pharmaceuticals Corporation (NASDAQ:RXII) - Duncan Research (NASDAQ:RXII)
www.duncanindependent.com - September 27 at 7:01 PM
News IconKeen Investors Find News on RXi Pharmaceuticals Corporation (NASDAQ:RXII) - Duncan Research (NASDAQ:RXII)
www.duncanindependent.com - September 24 at 6:24 PM
News IconRXi Pharmaceuticals to Present at the 16th Annual Biotech in Europe Forum for Global Partnering and (NASDAQ:RXII)
www.biomedreports.com - September 19 at 11:42 AM
finance.yahoo.com logoRXi Pharmaceuticals to Present at the 16th Annual Biotech in Europe Forum for Global Partnering and Investment Conference (NASDAQ:RXII)
finance.yahoo.com - September 19 at 11:42 AM
News IconRXi Pharma To Present At The Conference (NASDAQ:RXII)
www.biospace.com - September 13 at 12:02 PM
prnewswire.com logoRXi Pharmaceuticals to Present at the 4th Targeting Ocular Disorders Conference - PR Newswire (press release) (NASDAQ:RXII)
www.prnewswire.com - September 12 at 6:46 PM
finance.yahoo.com logoRXi Pharmaceuticals to Present at the 4th Targeting Ocular Disorders Conference (NASDAQ:RXII)
finance.yahoo.com - September 12 at 11:51 AM
capitalcube.com logoETF’s with exposure to RXi Pharmaceuticals Corp. : September 12, 2016 (NASDAQ:RXII)
www.capitalcube.com - September 12 at 11:51 AM
prnewswire.com logoRXi Pharmaceuticals Corporation Selected to Present at Cavendish Global Health Impact Forum - PR Newswire (press release) (NASDAQ:RXII)
www.prnewswire.com - September 8 at 6:50 PM
News IconRXi Pharmaceuticals to Present at the 9th Annual BioPharm America Conference (NASDAQ:RXII)
business.itbusinessnet.com - September 7 at 10:48 AM
finance.yahoo.com logoRXi Pharmaceuticals Corporation Selected to Present at Cavendish Global Health Impact Forum (NASDAQ:RXII)
finance.yahoo.com - September 7 at 10:48 AM
prnewswire.com logoRXi Pharmaceuticals to Present at the 9th Annual BioPharm America™ Conference - PR Newswire (press release) (NASDAQ:RXII)
www.prnewswire.com - September 6 at 11:55 AM
finance.yahoo.com logoRXi Pharmaceuticals to Present at the 9th Annual BioPharm America™ Conference (NASDAQ:RXII)
finance.yahoo.com - September 6 at 11:55 AM
capitalcube.com logoETF’s with exposure to RXi Pharmaceuticals Corp. : September 1, 2016 (NASDAQ:RXII)
www.capitalcube.com - September 1 at 10:18 AM
investornewswire.com logoWill RXI Pharmaceuticals Corporation (NASDAQ:RXII) Hit $25 Price Target? - Investor Newswire (NASDAQ:RXII)
www.investornewswire.com - August 22 at 11:50 AM
seekingalpha.com logoRXI Pharmaceuticals' (RXII) CEO Geert Cauwenbergh on Q2 2016 Results - Earnings Call Transcript (NASDAQ:RXII)
seekingalpha.com - August 12 at 10:29 AM
rttnews.com logoEARNINGS SUMMARY: Details of RXi Pharmaceuticals Corp. Q2 Earnings Report (NASDAQ:RXII)
www.rttnews.com - August 11 at 10:33 AM
finance.yahoo.com logoRXi Pharmaceuticals Reports Second Quarter 2016 Financial Results and Highlights Recent Corporate Developments (NASDAQ:RXII)
finance.yahoo.com - August 11 at 10:33 AM
investing.com logoRXi Pharmaceuticals: Samcyprone Data At AAD (NASDAQ:RXII)
www.investing.com - August 4 at 7:43 PM
ftsenews.co.uk logoRXI Pharmaceuticals Corporation (RXII) Updated Price Targets - FTSE News (NASDAQ:RXII)
www.ftsenews.co.uk - August 4 at 10:26 AM
finance.yahoo.com logoRXi Pharmaceuticals to Webcast Second Quarter 2016 Financial Results on Thursday, August 11, 2016 (NASDAQ:RXII)
finance.yahoo.com - July 28 at 7:02 AM
prnewswire.com logoRXi Pharmaceuticals to Present at the 2016 Summer Meeting of the American Academy of Dermatology - PR Newswire (press release) (NASDAQ:RXII)
www.prnewswire.com - July 21 at 10:05 AM
finance.yahoo.com logoRXi Pharmaceuticals to Present at the 2016 Summer Meeting of the American Academy of Dermatology (NASDAQ:RXII)
finance.yahoo.com - July 21 at 7:02 AM
capitalcube.com logoETF’s with exposure to RXi Pharmaceuticals Corp. : July 20, 2016 (NASDAQ:RXII)
www.capitalcube.com - July 20 at 12:51 PM
News IconRxi Pharmaceuticals Corporation (NASDAQ:RXII) Shorts Decreased by 5.68% After Short Covering - Press Telegraph (NASDAQ:RXII)
presstelegraph.com - July 19 at 8:21 AM
investornewswire.com logoStrong Sell Calls For RXI Pharmaceuticals Corporation (NASDAQ:RXII) At 0 - Investor Newswire (NASDAQ:RXII)
www.investornewswire.com - July 17 at 6:38 PM
News IconShares Moving Down on the Week: RXi Pharmaceuticals Corporation (NASDAQ:RXII) - Engelwood Daily (NASDAQ:RXII)
www.engelwooddaily.com - July 17 at 11:19 AM
News IconRxi Pharmaceuticals Corp Sentiment Improves on Better Stock Potential - Press Telegraph (NASDAQ:RXII)
presstelegraph.com - July 15 at 12:27 PM
kcregister.com logoCincinnati Bell Inc. (NYSE:CBB) increased 4.39%: RXi Pharmaceuticals Corporation (NASDAQ:RXII), Magellan ... - KC Register (NASDAQ:RXII)
www.kcregister.com - July 12 at 11:37 AM
investornewswire.com logoIs $25 Within Reach For RXI Pharmaceuticals Corporation (NASDAQ:RXII)? - Investor Newswire (NASDAQ:RXII)
www.investornewswire.com - July 10 at 6:28 PM
fiscalstandard.com logoBrokers Issue Average Price Target Of 4.08 On RXI Pharmaceuticals Corporation (RXII) - Fiscal Standard (NASDAQ:RXII)
www.fiscalstandard.com - July 10 at 11:14 AM
News IconRxi Pharmaceuticals Corporation (NASDAQ:RXII) Shorted Shares Decreased By 5.68% - Press Telegraph (NASDAQ:RXII)
presstelegraph.com - July 7 at 7:19 PM
News IconShare Volatility in Focus: RXi Pharmaceuticals Corporation (NASDAQ:RXII) - Engelwood Daily (NASDAQ:RXII)
www.engelwooddaily.com - July 6 at 11:51 AM
News IconCompany Stock Lower on the Week RXi Pharmaceuticals Corporation (NASDAQ:RXII) - Engelwood Daily (NASDAQ:RXII)
www.engelwooddaily.com - July 3 at 11:22 AM
investornewswire.com logoStrong Sell Calls Recommendations For RXI Pharmaceuticals Corporation (NASDAQ:RXII) At 0 - Investor Newswire (NASDAQ:RXII)
www.investornewswire.com - June 27 at 11:23 AM
News IconShare Volatility Check for: RXi Pharmaceuticals Corporation (NASDAQ:RXII) - Press Telegraph (NASDAQ:RXII)
presstelegraph.com - June 24 at 7:19 PM
investornewswire.com logoStrong Buy Calls Count For RXI Pharmaceuticals Corporation (NASDAQ:RXII) At 2 - Investor Newswire (NASDAQ:RXII)
www.investornewswire.com - June 21 at 11:34 AM
fiscalstandard.com logoThis Weeks Broker Views For RXI Pharmaceuticals Corporation (RXII) - Fiscal Standard (NASDAQ:RXII)
www.fiscalstandard.com - June 21 at 11:34 AM
investornewswire.com logoTrend Of Rating Given To RXI Pharmaceuticals Corporation (NASDAQ:RXII) - Investor Newswire (NASDAQ:RXII)
www.investornewswire.com - June 13 at 10:11 AM
capitalcube.com logoRXi Pharmaceuticals Corp. :RXII-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016 (NASDAQ:RXII)
www.capitalcube.com - June 6 at 12:11 PM
News IconNext Weeks Broker Price Targets For RXI Pharmaceuticals Corporation (RXII) - Share Trading News (NASDAQ:RXII)
www.sharetrading.news - May 31 at 7:19 AM
News IconRxi Pharmaceuticals Corporation (NASDAQ:RXII) Sellers Increased By 13.42% Their Shorts - HNN (NASDAQ:RXII)
hintsnewsnetwork.com - May 30 at 8:05 AM
investornewswire.com logoRXI Pharmaceuticals Corporation (NASDAQ:RXII) Closes At $2.17 - Investor Newswire (NASDAQ:RXII)
www.investornewswire.com - May 27 at 10:19 PM
News IconRxi Pharmaceuticals Corporation (NASDAQ:RXII) Shorts Decreased by 21.16% After Short Covering - Wall Street Hints and News (NASDAQ:RXII)
hintsnewsnetwork.com - May 26 at 8:04 AM
News IconPreview of HC Stock's Movement: Immunomedics, Inc. (NASDAQ:IMMU), RXi Pharmaceuticals Corp (NASDAQ:RXII) - share market updates (press release) (NASDAQ:RXII)
sharemarketupdates.com - May 23 at 9:43 AM
News IconAfter Last Week What Do Analysts Think Of RXI Pharmaceuticals Corporation (RXII) - Share Trading News (NASDAQ:RXII)
www.sharetrading.news - May 22 at 9:34 PM
tradecalls.org logoRevenue Update on RXi Pharmaceuticals Corp(NASDAQ:RXII) - Trade Calls (NASDAQ:RXII)
www.tradecalls.org - May 20 at 9:58 PM
finance.yahoo.com logoRXI PHARMACEUTICALS CORP Financials (NASDAQ:RXII)
finance.yahoo.com - May 20 at 1:04 PM
realistinvestor.com logoAlpha One Assigns Impact Score Of 0 To RXI Pharmaceuticals Corporation (NASDAQ:RXII) - RealistInvestor.com (NASDAQ:RXII)
www.realistinvestor.com - May 19 at 9:58 PM
News IconHC Stocks in Hub: CTI BioPharma Corp (CTIC), CytRx Corporation (CYTR), RXi Pharmaceuticals Corp (RXII) - share market updates (press release) (NASDAQ:RXII)
sharemarketupdates.com - May 12 at 5:09 PM

Social

RXi Pharmaceuticals Corp. (NASDAQ:RXII) Chart for Tuesday, September, 27, 2016


Last Updated on 9/27/2016 by MarketBeat.com Staff